Saul-Wilson syndrome – Genetics Home Reference

Allan I. Fleming

Ferreira CR, Xia ZJ, Clément A, Parry DA, Davids M, Taylan F, Sharma P, Turgeon CT, Blanco-Sánchez B, Ng BG, Logan CV, Wolfe LA, Solomon BD, Cho MT, Douglas G, Carvalho DR, Bratke H, Haug MG, Phillips JB, Wegner J, Tiemeyer M, Aoki K Undiagnosed Health conditions Community Scottish Genome Partnership, Nordgren A, Hammarsjö A, Duker AL, Rohena L, Hove HB, Ek J, Adams D, Tifft CJ, Onyekweli T, Weixel T, Macnamara E, Radtke K, Powis Z, Earl D, Gabriel M, Russi AHS, Brick L, Kozenko M, Tham E, Raymond KM, Phillips JA third, Tiller GE, Wilson WG, Hamid R, Malicdan MCV, Nishimura G, Grigelioniene G, Jackson A, Westerfield M, Bober MB, Gahl WA, Freeze HH. A Recurrent De Novo Heterozygous COG4 Substitution Potential customers to Saul-Wilson Syndrome, Disrupted Vesicular Trafficking, and Altered Proteoglycan Glycosylation. Am J Hum Genet. 2018 Oct 4103(four):553-567. doi: ten.1016/j.ajhg.2018.09.003.

Ferreira CR, Zein WM, Huryn LA, Merker A, Berger SI, Wilson WG, Tiller GE, Wolfe LA, Merideth M, Carvalho DR, Duker AL, Bratke H, Haug MG, Rohena L, Hove HB, Xia ZJ, Ng BG, Freeze HH, Gabriel M, Russi AHS, Brick L, Kozenko M, Earl DL, Tham E, Nishimura G, Phillips JA third, Gahl WA, Hamid R, Jackson AP, Grigelioniene G, Bober MB. Defining the medical phenotype of Saul-Wilson syndrome. Genet Med. 2020 Jan 17. doi: ten.1038/s41436-019-0737-1. [Epub in advance of print]

Next Post

Stephen Sherry, PhD, Selected as Acting Director, National Center for Biotechnology Information, National Library of Medicine

April 29, 2020 Countrywide Library of Medication Director, Patricia Flatley Brennan, RN, PhD, has named Stephen Sherry, PhD, as Performing Director, Countrywide Heart for Biotechnology Information and facts (NCBI) at the Countrywide Library of Medication (NLM) successful March 31, 2020. As Performing Director of NCBI, Dr. Sherry oversees a huge […]